Key Segmentation:
By Service Type
-
Contract Manufacturing
-
Drug Development Services
-
Analytical & Testing Services
-
Regulatory & Compliance Services
-
Others
By Application
-
Viral Vaccines
-
Protein Replacement Therapies
-
Cancer Immunotherapy
-
Rare Genetic Disease Therapies
-
Others
By Indication
-
Infectious Diseases
-
Metabolic & Genetic Diseases
-
Oncology
-
Cardiovascular Diseases
-
Others
By End User
-
Biotechnology Companies
-
Pharmaceutical Companies
-
Academic & Research Institutions
-
Government & Non-Profit Organizations
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The mRNA Therapeutics Contract Development & Manufacturing Market is expected to grow at a CAGR of 11.18% from 2026 to 2035.
The mRNA Therapeutics Contract Development & Manufacturing Market was valued at USD 3.85 Billion in 2025.
The expanding mRNA therapeutic pipeline beyond infectious disease vaccines into oncology, rare genetic disease, and protein replacement therapy creating above-average CDMO service procurement, and personalized medicine's adoption of patient-specific mRNA neoantigen cancer vaccines creating premium manufacturing service relationships.
Viral Vaccines dominated the market with approximately 52% share in 2025, while Cancer Immunotherapy is the fastest growing segment.
North America dominated the mRNA Therapeutics Contract Development & Manufacturing Market with approximately 45% of global revenues in 2025, while Asia Pacific is the fastest-growing region.